‘Frankenfish’ Salmon Approval Needs FDA Redo Over Escape Fears

摘要

The Food and Drug Administration needs to take a second look at the environmental consequencesof the potential escape of genetically-engineered salmon-so-called frankenfish-from captivity, aCalifornia federal court ruled Thursday.The agency studied the likelihood of escape and concluded that the modified fish were unlikely tosurvive. However, the FDA failed to analyze what would happen to normal salmon if the modifiedfish were able to establish themselves in the wild, according to the U.S. District Court for theNorthern District of California.